RXi Pharmaceuticals rxipharma.com

RXi Pharmaceuticals (NASDAQ: RXII) is a biotechnology company focused on discovering, developing, and commercializing therapies addressing unmet medical needs using RNA-targeted and immunotherapy technologies.

RXi Pharmaceuticals (NASDAQ: RXII) is a biotechnology company focused on discovering, developing, and commercializing therapies addressing unmet medical needs using RNA-targeted and immunotherapy technologies.

See All Exits Recent Exits

Phone: 508-767-3861

Fax:

257 Simarano Drive
Suite 101
Marlborough, 1752
Massachusetts, United States

RXi Pharmaceuticals - Investments & Acquisitions

Show Real Data RXi Pharmaceuticals Investments
See all Recent Investments
Date Company Round Amount Co-investors
2016-10-13MirImmuneAcquired
2011-09-26Galena BiopharmaSpinoff / Spinout
2011-04-19AptheraAcquired
See all 3 investments